Inkcazo
I-Omeprazole yethu ephakathi kwe-2.3.5-Trimethyl-4-nitropyridine-N-oxide yenziwe ngokucophelela ukuze ihlangabezane nemigangatho ephezulu yoshishino, iqinisekisa ukucoceka kwayo kunye nokusebenza kwayo kwaye ingasetyenziselwa kwiinkqubo ezahlukeneyo zeekhemikhali kunye neyeza.Ngokwakhiwa kwayo okuchanekileyo kunye nomgangatho okhethekileyo, le khompawundi lukhetho olugqibeleleyo kubaphandi, izazinzulu kunye neengcali zonyango ezijonga abaphakathi abathembekileyo, abakumgangatho ophezulu kwiiprojekthi zabo.
Esi siphakathi sidlala indima ebalulekileyo ekuvelisweni kwe-omeprazole, ichiza elisetyenziswa ngokubanzi ukunyanga izifo ezinxulumene ne-asidi ezifana nesifo se-gastroesophageal reflux (GERD), izilonda ze-peptic, kunye ne-zolin (i-Guardian-Ellison syndrome).Njengenxalenye ephambili kwi-synthesis ye-omeprazole, i-omeprazole yethu ephakathi kwe-2.3.5-trimethyl-4-nitropyridine-N-oxide iququzelela ukuveliswa okusebenzayo kunye neendleko ezisebenzayo zale mayeza abalulekileyo.
Khetha Thina
I-JDK iphethe izixhobo zokuvelisa iklasi yokuqala kunye nezixhobo zokulawula uMgangatho, oqinisekisa ukunikezelwa okuzinzile kwe-API intermediates.Iqela lobuchwephesha liqinisekisa iR&D ngemveliso.Ngokuchasene nazo zombini, sikhangela i-CMO kunye ne-CDMO kwimarike yasekhaya neyamanye amazwe.
![I-Tofacitinib Intermediate (2R, 3R) -2,3-bis [(4-methylbenzoyl) oxy] succinic acid kunye (3R, 4R) - N, 4-dimethyl-1- (phenylmethyl) -3-piperidine amine CAS No. 477600 -71-8](http://cdn.globalso.com/jdkhc/2R-3R-23-bis-4-methylbenzoyl-oxy-succinic-acid-and-3R-4R-N-4-dimethyl-1-phenylmethyl-3-piperidine-amine.jpg)
